Aligos Therapeutics (ALGS) EBIT Margin (2019 - 2026)
Aligos Therapeutics (ALGS) recorded EBIT Margin of -951.55% in Q1 2026, up 5235.91 percentage points from -6187.46% a year earlier and up 11956.14 percentage points from the prior quarter.
Powered by 
Analysis
Aligos Therapeutics (ALGS) EBIT Margin (2019 - 2026) Analysis & Trends
For FY2025, Aligos Therapeutics reported EBIT Margin of -4024.93%, down 1555.98 percentage points from FY2024.
- Annual EBIT Margin has declined for three straight years, with a four-year change of -1081.11 percentage points (FY2021 to FY2025).
- Across earlier years, EBIT Margin came in at -2468.96% in FY2024 (-1525.21 pp), -943.75% in FY2023 (-242.08 pp), -701.66% in FY2022 (+2242.16 pp) and -2943.82% in FY2021.
- The Q1 2026 figure is the highest quarterly EBIT Margin since Q3 2023.
- On a year-over-year basis, EBIT Margin rose in two of the last eight quarters, with an average year-over-year change of -1726.11 percentage points.
- Peak year-over-year performance for EBIT Margin in the last five years was a gain of 9698.78 percentage points in Q4 2022, against a drop of 9514.46 percentage points in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at -12907.69% (Q4 2025), -3827.40% (Q3 2025) and -1924.04% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,139.37 Bn | 1,107.95 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 618.39 Bn | 536.92 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 508.07 Bn | 481.19 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.07 Bn | 321.44 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.65 Bn | 262.64 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 263.08 Bn | 236.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 236.65 Bn | 192.05 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 192.73 Bn | 166.92 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.28 Bn | 117.93 Bn | 10.94 Bn | 28.37% |
| 10 | Aligos Therapeutics | 52.52 Mn | -275.89 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -951.55% |
| Dec 31, 2025 | -12,907.69% |
| Sep 30, 2025 | -3,827.40% |
| Jun 30, 2025 | -1,924.04% |
| Mar 31, 2025 | -6,187.46% |
| Dec 31, 2024 | -3,393.23% |
| Sep 30, 2024 | -1,610.48% |
| Jun 30, 2024 | -2,489.54% |
| Mar 31, 2024 | -3,176.66% |
| Dec 31, 2023 | -1,294.03% |
| Sep 30, 2023 | -885.38% |
| Jun 30, 2023 | -445.76% |
| Mar 31, 2023 | -925.98% |
| Dec 31, 2022 | -641.28% |
| Sep 30, 2022 | -461.47% |
| Jun 30, 2022 | -552.21% |
| Mar 31, 2022 | -1,383.00% |
| Dec 31, 2021 | -10,340.05% |
| Sep 30, 2021 | -2,151.46% |
| Jun 30, 2021 | -1,913.59% |
API Access
Aligos Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();